Bayer enters pact to expand research

Article Abstract:

Bayer AG is collaborating with Exelixis Pharmaceuticals Inc. to form the research venture company, Genoptera L.L.C. which is to expand Bayer's research of agrochemicals. Bayer remains committed to agrochemicals because of the strength it holds in that market and plans to focus research on nematocides, or worm killers.

Agricultural Chemicals, Soil Fumigants, Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing, Agricultural chemicals industry, Nematocides, Fumigants, Soils, Bayer AG, Exelixis Inc., GenOptera L.L.C.

---

BASF beats out competition to buy Cyanamid of U.S

Article Abstract:

BASF AG has reached an agreement to acquire the agricultural products operations of American Home Products Corp. for $3.8 billion (3.9 billion euros). BASF outbidded other rivals for the operations.

Asset sales & divestitures, Acquisitions & mergers, Chemicals & Allied Products, Chemical Manufacturing, CHEMICALS AND ALLIED PRODUCTS, Agricultural chemicals, not elsewhere classified, Insecticides, Mergers, acquisitions and divestments, Chemicals, BASF AG, Chemical industry, American Home Products Corp., AHP, Pesticides industry

---

Medarex goes to Europe for alliance on new unit

Article Abstract:

Medarex Inc. (New Jersey, USA) opened a new unit called Genmab ApS (Berlin, Germany) with financial aid from BankInvest (Denmark). The biomedical research company hopes to develop new human antibodies for treating inflammatory diseases using cutting edge technology. The German government has recently decided to make the country a more friendly place for biotech companies. So, the Berlin location is not unexpected. The alliance between Medarex and BankInvest shows a change in the biotech industry. Previously, earnings were rather flat, with new investments down 44 percent.

Organizational history, Pharmaceutical Preparation Manufacturing, Vaccines & Antigens for Human Use, Biological Product (except Diagnostic) Manufacturing, Biological products exc. diagnostic, Antibodies for Human Use, Planning, Finance, Vaccines industry, Biological products industry, Biological products, Antibodies, Medarex Inc., MEDX, Genmab ApS, BankInvest Development Venture Fund

Similar abstracts:

• Abstracts: Newmont Mining to buy Normandy and Franco-Nevada for 5.43 billion euros. AngloGold bids for Normandy in share deal
• Abstracts: Aliant acquisition could help Alltel expand in U.S. and improve service. Qwest acquires part of KPN stake in KPNQwest
• Abstracts: Thomson-CSF discusses full acquisition of Racal. Thomson to pay 2.11 billion euros for Racal. Acquisition may be boon to Thomson
• Abstracts: Orange deal lands victory in Europe for Freshfields. Accession in progress. S&M whips rivals as Norton rises
• Abstracts: 3i, Vantec Managers join forces to buy stake from Nissan. GM might soon buy assets. GM will buy remainder of Saab from Investor AB

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.